(Q57021209)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30290779%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

title

Conventional immunosuppressive therapy in severe Behcet's Uveitis: the switch rate to the biological agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30290779%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

0 references

1 reference

Hande Celiker

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30290779%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Haluk Kazokoglu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30290779%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

Haner Direskeneli

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30290779%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

language of work or name

English

0 references

publication date

5 October 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30290779%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30290779%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30290779%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30290779%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

page(s)

261

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30290779%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

26 April 2020

copyright license

start time

5 October 2018

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease

1 reference

12 December 2020

Behçet's syndrome: treatment with recombinant leukocyte alpha-interferon

1 reference

12 December 2020

1 reference

12 December 2020

The use of interferon alpha in Behçet disease: review of the literature

1 reference

12 December 2020

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

1 reference

12 December 2020

Behçet's disease: ocular effects and treatment

1 reference

12 December 2020

Biologics in the treatment of uveitis

1 reference

12 December 2020

Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity

1 reference

12 December 2020

Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behçet disease

1 reference

12 December 2020

Safety and effectiveness of interferon alpha-2a in treatment of patients with Behçet's uveitis refractory to conventional treatments

1 reference

12 December 2020

Long-term efficacy and safety of low-dose and dose-escalating interferon alfa-2a therapy in refractory Behçet uveitis

1 reference

12 December 2020

Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients.

1 reference

12 December 2020

10.1186/S12886-018-0929-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30290779%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30290779%20AND%20SRC:MED&resulttype=core&format=json

26 April 2020

1 reference